Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
NYR-BI03
Myocardial Ischemia
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2-May-2025
Phase I Clinical Trial Dosing Update No 2
17-Apr-2025
Results of Meeting
15-Apr-2025
Quarterly Activities Report and Appendix 4C
9-Apr-2025
Notice of Initial Substantial Holder - M Azzi
9-Apr-2025
Phase I Clinical Trial Dosing Update No 1
7-Apr-2025
Significant Neuroprotection in Traumatic Brain Injury Study
31-Mar-2025
First Cohort Dosed in Nyradas Phase I Clinical Trial
17-Mar-2025
Nyrada Commences Phase I Clinical Trial Recruitment
12-Mar-2025
2025 EGM Letter to Shareholders, Notice of Meeting and Proxy
18-Feb-2025
Nyrada Half Year Results FY2025
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
Next
